Share Options Awarded

Summary by AI BETAClose X

Bioventix plc announced on April 20, 2026, the award of share options under its 2020 Share Option Plan to its CEO, Peter Harrison, for 32,811 options at an exercise price of £17.75, bringing his total to 52,622, and to its CFO, Bruce Hiscock, for 9,967 options at the same exercise price, bringing his total to 14,394. These options vest between three and ten years and become exercisable upon the company achieving over £1.0 million in revenue from a commercial diagnostic partner for its neurological blood test.

Disclaimer*

Companies

Bioventix (BVXP)
UK 100

Latest directors dealings